U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06841653) titled 'A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer.' on Feb. 18.
Brief Summary: Prediction of preoperative endometrial biopsy: the evolution from hyperplasia to cancer, the prognosis and the risk of recurrence. Intelligence methods artificial risk will be used to redefine the current risk classes including our profile immuno-mutational to provide a more precise characterization and closer to the real prognosis of the patient.
Study Start Date: June 20, 2024
Study Type: OBSERVATIONAL
Condition:
Endometrium Cancer
Recruitment Status: RECRUITING
Sponsor: Regina Elena Canc...